TBI

·MeSH: REM Sleep Behavior Disorder

8 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(4)

Drug	Company
allopregnanolone	GH Research PLC (GHRS)
onp-002	ORAGENICS INC (OGEN)
Tranexamic Acid	UNITED THERAPEUTICS Corp (UTHR)
Valproic Acid	UNITED THERAPEUTICS Corp (UTHR)

Phase 1(1)

Drug	Company
Zoledronic acid	UNITED THERAPEUTICS Corp (UTHR)

Preclinical(3)

BioSniper tracks 8 drugs in development for TBI across 5 companies.

There are 1 clinical trial targeting TBI tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.